Sara M. Schmitt

2.3k citations

20 papers · 1.9k indexed · 2 hit papers · h-index 14

Co-authors: Q. Ping Dou Michael Frezza Jyoti Kanwar Daniela Buac Dajena Tomco Di Chen Andrew M. Davenport S.S. Hindo
Topics: Ubiquitin and proteasome pathways (12 papers)Metal complexes synthesis and properties (7 papers)Trace Elements in Health (5 papers)
Cited by: Oncology Hematology Organic Chemistry
Journals: PLoS ONE Clinical Cancer Research Inorganic Chemistry
Partner nations: United States China Italy

In The Last Decade

Sara M. Schmitt

20 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

2011 640 citations Michael Frezza, Sara M. Schmitt et al. Current Cancer Drug Targets profile →
Novel Metals and Metal Complexes as Platforms for Cancer Therapy

2010 462 citations Michael Frezza, S.S. Hindo et al. Current Pharmaceutical Design profile →

Peers

Countries citing papers authored by Sara M. Schmitt

Since Specialization

Citations

This map shows the geographic impact of Sara M. Schmitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara M. Schmitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara M. Schmitt more than expected).

Fields of papers citing papers by Sara M. Schmitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara M. Schmitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara M. Schmitt. The network helps show where Sara M. Schmitt may publish in the future.

Co-authorship network of co-authors of Sara M. Schmitt

This figure shows the co-authorship network connecting the top 25 collaborators of Sara M. Schmitt. A scholar is included among the top collaborators of Sara M. Schmitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara M. Schmitt. Sara M. Schmitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair 2018 ·Clinical Cancer Research ·(unknown),(unknown),David T. Hoang,Lei Gu,Vitali Alexeev,(unknown),(unknown),Jonathan R. Brody,Ulrich Rodeck,Carmen Bergom,(unknown),(unknown),William A. See,Sara M. Schmitt,Marja T. Nevalainen	46
2	Involvement of ALAD‐20S Proteasome Complexes in Ubiquitination and Acetylation of Proteasomal α2 Subunits 2015 ·Journal of Cellular Biochemistry ·Sara M. Schmitt,Christine Neslund‐Dudas,Min Shen,(unknown),Bharati Mitra,Q. Ping Dou	10
3	Inhibition of the 26S proteasome as a possible mechanism for toxicity of heavy metal species 2014 ·Journal of Inorganic Biochemistry ·Dajena Tomco,Sara M. Schmitt,Mary Jane Heeg,Q. Ping Dou,Cláudio N. Verani	2
4	Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia 2014 ·PLoS ONE ·Chiara Nardon,Sara M. Schmitt,Huanjie Yang,Jian Zuo,Dolores Fregona,Q. Ping Dou	45
5	Metal-based 2,3-indolinedione derivatives as proteasome inhibitors and inducers of apoptosis in human cancer cells 2014 ·International Journal of Molecular Medicine ·Pengfei Zhang,Caifeng Bi,Sara M. Schmitt,Xin Li,Yuhua Fan,Nan Zhang,Q. Ping Dou	16
6	Targeting the ubiquitin–proteasome system for cancer therapy 2013 ·Expert Opinion on Therapeutic Targets ·Min Shen,Sara M. Schmitt,Daniela Buac,Q. Ping Dou	165
7	From Bortezomib to other Inhibitors of the Proteasome and Beyond 2013 ·Current Pharmaceutical Design ·Daniela Buac,Min Shen,Sara M. Schmitt,Fathima R. Kona,Rahul R. Deshmukh,Zhen Zhang,Christine Neslund‐Dudas,Bharati Mitra,Q. Ping Dou	118
8	Chemotherapeutic inhibitors in the treatment of prostate cancer 2013 ·Expert Opinion on Pharmacotherapy ·Rahul Deshmukh,Sara M. Schmitt,Clara Hwang,Q. Ping Dou	5
9	Novel Polypyridyl chelators deplete cellular zinc and destabilize the X‐linked inhibitor of apoptosis protein (XIAP) prior to induction of apoptosis in human prostate and breast cancer cells 2012 ·Journal of Cellular Biochemistry ·Jian Zuo,Sara M. Schmitt,Zhen Zhang,(unknown),(unknown),Caifeng Bi,Jeremy J. Kodanko,Q. Ping Dou	17
10	Association of Metals and Proteasome Activity in Erythrocytes of Prostate Cancer Patients and Controls 2012 ·Biological Trace Element Research ·Christine Neslund‐Dudas,Bharati Mitra,Ashoka Kandegedara,Di Chen,Sara M. Schmitt,Min Shen,Qiuzhi Cindy Cui,Benjamin A. Rybicki,Q. Ping Dou	15
11	1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity 2012 ·JBIC Journal of Biological Inorganic Chemistry ·Zhen Zhang,Caifeng Bi,Sara M. Schmitt,Yuhua Fan,Lili Dong,Jian Zuo,Q. Ping Dou	57
12	Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells 2012 ·Mini-Reviews in Medicinal Chemistry ·Daniela Buac,Sara M. Schmitt,(unknown),Fathima R. Kona,Q. Ping Dou	104
13	Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectivesbreakdown → 2011 ·Current Cancer Drug Targets ·(unknown),Michael Frezza,Sara M. Schmitt,Jyoti Kanwar,Q. Ping Dou	640
14	Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy 2011 ·Current Topics in Medicinal Chemistry ·Michael Frezza,Sara M. Schmitt,Q. Ping Dou	71
15	Inhibition of the purified 20S proteasome by non-heme iron complexes 2011 ·Metallomics ·(unknown),Sara M. Schmitt,Q. Ping Dou,Jeremy J. Kodanko	4
16	Effects of tethered ligands and of metal oxidation state on the interactions of cobalt complexes with the 26S proteasome 2011 ·Journal of Inorganic Biochemistry ·Dajena Tomco,Sara M. Schmitt,(unknown),Mary Jane Heeg,Q. Ping Dou,Cláudio N. Verani	12
17	Use of proteasome inhibitors in anticancer therapy 2011 ·Sara M. Schmitt,(unknown),Q. Ping Dou	1
18	Inhibition of tumor cellular proteasome activity by triptolide extracted from the Chinese medicinal plant 'thunder god vine'. 2011 ·PubMed ·Li Lu,Jyoti Kanwar,Sara M. Schmitt,Qiuzhi Cindy Cui,Chuanyin Zhang,Cong Zhao,Q. Ping Dou	33
19	Synthesis, Characterization, and Reactivity of the Stable Iron Carbonyl Complex [Fe(CO)(N4Py)](ClO₄)₂: Photoactivated Carbon Monoxide Release, Growth Inhibitory Activity, and Peptide Ligation 2011 ·Inorganic Chemistry ·(unknown),Sara M. Schmitt,Q. Ping Dou,Jeremy J. Kodanko	90
20	Novel Metals and Metal Complexes as Platforms for Cancer Therapybreakdown → 2010 ·Current Pharmaceutical Design ·Michael Frezza,S.S. Hindo,Di Chen,Andrew M. Davenport,Sara M. Schmitt,Dajena Tomco,Q. Ping Dou	462

About Sara M. Schmitt

Sara M. Schmitt is a scholar working on Oncology, Nutrition and Dietetics and Toxicology, having authored 20 papers that have together received 1.9k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (12 papers), Metal complexes synthesis and properties (7 papers) and Trace Elements in Health (5 papers). The work is most often cited by research in Oncology (834 citations), Hematology (187 citations) and Organic Chemistry (451 citations). Sara M. Schmitt has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Q. Ping Dou, Michael Frezza, Jyoti Kanwar, Daniela Buac, Dajena Tomco, Di Chen, Andrew M. Davenport, S.S. Hindo, Min Shen and Fathima R. Kona. Their work appears in journals such as PLoS ONE, Clinical Cancer Research and Inorganic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact